Certara (CERT) to Release Quarterly Earnings on Monday

Key Points

• Certara will report Q1 2026 results before the market opens on Monday, May 11, with analysts expecting $0.11 EPS and $106.14M in revenue, and the company has set FY2026 guidance of $0.44–$0.48 EPS.
• In the prior quarter Certara missed EPS estimates (reported $0.09 vs. $0.11 expected) while revenue rose 3.2% year-over-year, and analysts on average forecast $0 EPS for the current and next fiscal years.
• Shares sit at roughly a $947.5M market cap with a negative P/E, a consensus analyst rating of Hold and an average price target of $10.44, and institutional investors own about 74% of the stock.

Certara (NASDAQ:CERT - Get Free Report) will likely be releasing its Q1 2026 results before the market opens on Monday, May 11th. Analysts expect the company to announce earnings of $0.11 per share and revenue of $106.14 million for the quarter. Certara has set its FY 2026 guidance at 0.440-0.480 EPS. Parties are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Monday, May 11, 2026 at 8:30 AM ET.

Certara (NASDAQ:CERT - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.02). The business had revenue of $103.65 million during the quarter, compared to analysts' expectations of $103.23 million. Certara had a positive return on equity of 4.20% and a negative net margin of 0.38%.Certara's revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.15 EPS. On average, analysts expect Certara to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Certara Stock Performance

Shares of NASDAQ:CERT opened at $6.18 on Monday. The company has a quick ratio of 2.05, a current ratio of 2.05 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $947.52 million, a price-to-earnings ratio of -618.00 and a beta of 1.53. The firm has a 50 day moving average of $6.27 and a 200 day moving average of $8.23. Certara has a 52 week low of $5.19 and a 52 week high of $13.88.

Analyst Upgrades and Downgrades

CERT has been the topic of several recent research reports. Leerink Partners reaffirmed an "outperform" rating and set a $10.00 target price on shares of Certara in a research report on Thursday, February 26th. Craig Hallum cut Certara from a "buy" rating to a "hold" rating and set a $10.00 target price on the stock. in a research report on Friday, February 27th. KeyCorp dropped their target price on Certara from $10.00 to $8.00 and set an "overweight" rating on the stock in a research report on Monday, April 13th. Barclays reaffirmed an "equal weight" rating and set a $8.00 target price on shares of Certara in a research report on Friday, March 6th. Finally, TD Cowen restated a "buy" rating on shares of Certara in a report on Thursday, February 26th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $10.44.

Institutional Trading of Certara

Large investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. grew its position in Certara by 2,733.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,975 shares of the company's stock worth $26,000 after purchasing an additional 2,870 shares during the last quarter. Osaic Holdings Inc. grew its position in Certara by 50.7% during the 2nd quarter. Osaic Holdings Inc. now owns 3,491 shares of the company's stock worth $41,000 after purchasing an additional 1,175 shares during the last quarter. Tower Research Capital LLC TRC grew its position in Certara by 499.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,917 shares of the company's stock worth $69,000 after purchasing an additional 4,930 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in Certara during the 2nd quarter worth approximately $83,000. Finally, Engineers Gate Manager LP purchased a new stake in Certara during the 4th quarter worth approximately $92,000. Hedge funds and other institutional investors own 73.96% of the company's stock.

About Certara

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company's platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company's offerings are divided into software tools and consulting services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.